EUVIMEDOpdag EUVIMED
EditorialKommentar

Long COVID : Does SARS‐CoV ‐2 induce lingering brain lesions?

Jacques Hugon

European Journal of Neurology · 2023

DOI: 10.1111/ene.15751 ↗

At a glance

Editorial in European Journal of Neurology, 2023. Written by Jacques Hugon. Institution: Cognitive Neurology Center, University of Paris City Lariboisière Hospital APHP, Paris, France. Major MEDLINE topics: COVID-19, Nervous System Diseases. Cited 2 times so far (Crossref); 10 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Hundreds of millions of COVID cases have been reported so far and long‐term lingering clinical symptoms are frequent and are called long COVID. Neurological signs including cognitive complaints are often described in long Covid. In COVID patients, the Sars‐Cov‐2 virus can reach the brain and could be responsible for cerebral anomalies observed in long COVID. Long‐term careful clinical follow‐up of these patients is necessary to detect early signs of neurodegeneration.

Subjects

MeSH terms (MEDLINE)

COVID-19Nervous System DiseasesHumansSARS-CoV-2Post-Acute COVID-19 SyndromeBrain

Author keywords

COVID-19cognitive disordersinfectionsmild cognitive impairmentneurological disorders

Authors and institutions

  • Cognitive Neurology Center, University of Paris City Lariboisière Hospital APHP, Paris, France.

Cite

APA

Hugon, J. (2023). Long COVID : Does SARS‐CoV ‐2 induce lingering brain lesions?. European Journal of Neurology. https://doi.org/10.1111/ene.15751

Vancouver

Hugon J. Long COVID : Does SARS‐CoV ‐2 induce lingering brain lesions?. European Journal of Neurology. 2023. doi:10.1111/ene.15751

BibTeX
@article{Hugon2023,
  author = {Hugon, Jacques},
  title = {Long COVID : Does SARS‐CoV ‐2 induce lingering brain lesions?},
  journal = {European Journal of Neurology},
  year = {2023},
  doi = {10.1111/ene.15751}
}
Start for free →